SCHEMBL5339874

SCHEMBL5339874

CCCc1ccc(C(=O)Nc2ccc(C(C)=O)cc2)cc1

nearest known ligand 0.61

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 3/20 0.61
PLK1 P53350 1/20 0.60
KDM4E B2RXH2 3/20 0.58
SMN1; SMN2 Q16637 1/20 0.57
ABCG2 Q9UNQ0 2/20 0.56
ENPP1 P22413 1/20 0.56
APOBEC3G Q9HC16 1/20 0.56
ALDH1A1 P00352 2/20 0.55
GAA P10253 2/20 0.55
LMNA P02545 1/20 0.55
TDP1 Q9NUW8 1/20 0.55
POLB P06746 3/20 0.54
CTDSP1 Q9GZU7 2/20 0.54
KMT2A Q03164 1/20 0.54
NR1H4 Q96RI1 1/20 0.54
NPC1 O15118 1/20 0.53
GALR3 O60755 1/20 0.53
RAB9A P51151 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4326686 0.91 TRPV1 (0.76) TRPV1PLK1KDM4ESMN1; SMN2ALDH1A1
SCHEMBL4122562 0.89 MAPT (0.62) PLK1SMN1; SMN2ABCG2ALDH1A1GAA
SCHEMBL4747814 0.87 TRPV1 (0.61) TRPV1PLK1KDM4EABCG2ENPP1
SCHEMBL8361574 0.87 NPC1 (0.71) TRPV1PLK1KDM4ESMN1; SMN2ABCG2
SCHEMBL5388219 0.87 TRPV1 (0.61) TRPV1PLK1KDM4EABCG2ENPP1
SCHEMBL8408236 0.86 KDM4E (0.74) TRPV1PLK1KDM4ESMN1; SMN2ALDH1A1
SCHEMBL13514013 0.85 TRPV1 (0.82) TRPV1PLK1ABCG2ALDH1A1POLB
SCHEMBL4173457 0.85 TRPV1 (0.72) TRPV1KDM4ESMN1; SMN2ABCG2GAA
SCHEMBL9978841 0.85 TRPV1 (0.58) TRPV1PLK1KDM4EABCG2ENPP1
SCHEMBL4609340 0.84 NPC1 (0.63) TRPV1PLK1KDM4ESMN1; SMN2ABCG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7230020-B2 11β-hydroxysteroid dehydrogenase inhibitors STERIX LIMITED (GB) 2007-06-12 US disclosed
US-7230020-B2 11β-hydroxysteroid dehydrogenase inhibitors STERIX LIMITED (GB) 2007-06-12 US disclosed
US-7230020-B2 11β-hydroxysteroid dehydrogenase inhibitors STERIX LIMITED (GB) 2007-06-12 US disclosed
EP-1675844-A1 PHENYL CARBOXAMIDE AND SULFONAMIDE DERIVATIVES FOR USE AS 11-BETA-HYDROXYSTEROID DEHYDROGENASE Sterix Limited (GB) 2006-07-05 EP disclosed
US-20050227987-A1 11beta-hydroxysteroid dehydrogenase inhibitors STERIX LIMITED (GB) 2005-10-13 US disclosed
WO-2005042513-A1 PHENYL CARBOXAMIDE AND SULFONAMIDE DERIVATIVES FOR USE AS 11-BETA-HYDROXYSTEROID DEHYDROGENASE STERIX LIMITED (GB) 2005-05-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050227987-A1 11beta-hydroxysteroid dehydrogenase inhibitors HSD3B1, HSD3B2, HSD17B3 TRPV1 4868/4885PLK1 3346/4885KDM4E 1404/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.